ANALYSIS: Vital investors foot the bill for ditching a dud idea

ANALYSIS: Vital investors foot the bill for ditching a dud idea
Jenny Ruth
By Jenny Ruth Sept. 2 (BusinessDesk) - Investors were mightily relieved when Vital Healthcare Property Trust’s manager announced in May that Vital wouldn’t be party to buying Healthscope properties for A$1.25 billion. Trading in Vital speaks volumes: the unit price jumped from $2.12 on May 9, the day before Canada-based NorthWest Healthcare Properties Real Estate Investment Trust’s announcement, to as high at $2.65 in July. But the relief is rather like the deliverance you feel when you stop banging your head against a brick wall. I...

More Opinion

Aroa comes unstuck thanks to US partnership
Markets

Brian Robins: Aroa comes unstuck thanks to US partnership

The Auckland-based medtech firm is under pressure.

Brian Robins 26 Mar 2025
Hurray for the Big Tech whistleblowers
Opinion

Peter Griffin: Hurray for the Big Tech whistleblowers

Individuals who turn on their former employers almost always destroy their careers.

Peter Griffin 26 Mar 2025
Jim Grenon’s ‘extremist’ problem
Markets

Pattrick Smellie: Jim Grenon’s ‘extremist’ problem

Jim Grenon's letter to NZME shows commercial, if not news, acumen.

Pattrick Smellie 25 Mar 2025
Rule-changers, by AI
Opinion

David Chaplin: Rule-changers, by AI

Some regulators share more than others.

David Chaplin 25 Mar 2025